Oratz R, Bystryn J C
Kaplan Cancer Center, New York University School of Medicine, New York.
Dermatol Clin. 1991 Oct;9(4):669-82.
The growth of melanoma in humans depends not only on the malignant potential of the tumor but also on the patient's immune response to the melanoma. As a result, a variety of strategies have evolved to treat melanoma by stimulating antitumor immune responses to melanoma. This article reviews the different approaches being taken and the results obtained to date.
人类黑色素瘤的生长不仅取决于肿瘤的恶性潜能，还取决于患者对黑色素瘤的免疫反应。因此，已经发展出多种通过刺激对黑色素瘤的抗肿瘤免疫反应来治疗黑色素瘤的策略。本文综述了目前正在采用的不同方法以及迄今所取得的成果。
